Image Source : EquityBulls
Lasa Supergenerics Ltd has announced it cannot resume operations at its Lote Parshuram manufacturing facility following a fire incident in May 2025, citing extensive damage and regulatory hurdles.
Key updates:
-
The fire caused significant harm to inventory, machinery, and administrative infrastructure.
-
Despite initial optimism, the company now confirms operations cannot restart immediately due to compliance and restoration challenges.
Operational impact:
-
Production remains halted, affecting supply of veterinary APIs and other pharmaceutical ingredients.
-
The company is actively working on revamping the facility, with a focus on safety upgrades and statutory clearances.
-
No casualties were reported, but the disruption has triggered stakeholder concerns over business continuity.
Forwardlooking statement:
-
Lasa assures investors and partners of its commitment to recovery and longterm resilience.
-
Updates on restoration timelines and financial implications are expected in subsequent disclosures.
Sources: Lasa Supergenerics Ltd (Regulation 30 Disclosure), Rediff MoneyWiz, MarketScreener
Advertisement
Advertisement